AstraZeneca

AstraZeneca

AstraZenecaAstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca.com.

AstraZeneca RSS Channel

Filters
List of articles in category AstraZeneca
Title Published Date
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health 17 July 2023
AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge 17 March 2023
Acquisition of Neogene Therapeutics completed 17 January 2023
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline 09 January 2023
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy 29 November 2022
Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19 29 September 2022
Vaxzevria approved in the EU as third dose booster against COVID-19 26 May 2022
Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations 20 April 2022
Evusheld long-acting antibody combination recommended for approval in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 24 March 2022
New Vaxzevria data further support its use as third dose booster 13 January 2022
Vaxzevria significantly boosted antibody levels against Omicron 23 December 2021
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world 16 November 2021
AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19 23 August 2021
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity 27 July 2021
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe 18 June 2021
UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective 18 March 2021
Update on the safety of COVID-19 Vaccine AstraZeneca 14 March 2021
AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization 16 February 2021
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials 03 February 2021
COVID-19 Vaccine AstraZeneca recommended for use in the EU 29 January 2021